ArticleCurrent oncology (Toronto, Ont.)2020

Osteopontin level and promoter polymorphism in patients with metastatic breast cancer.

M A Elbaiomy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.